Decoding Progression Risk in IgM-MGUS and Asymptomatic Waldenström Macroglobulinemia Through Genomic Profiling

Highlight

  • Whole-exome sequencing reveals increasing mutation burden from IgM-MGUS to symptomatic Waldenström macroglobulinemia.
  • Specific gene mutations (CD79B, ARID1A, CREBBP) and higher MYD88L265 variant allele frequency correlate with progression in asymptomatic WM.
  • MYD88 wild-type IgM-MGUS patients have distinct genomic profiles compared to their MYD88-mutant counterparts.
  • Aneuploidy burden associates significantly with the risk of progression to symptomatic disease.

Study Background

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply